Plasma levels of phosphorylated forms of tau are increasingly being used in the diagnosis of Alzheimer’s disease, and levels of phosphorylated tau and total tau rise acutely after mild TBI [108,109,110,111]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.